GlySure is the leader in continuous glucose monitoring (CGM) for critical care. The Company leverages its development team’s collective successes in intravascular sensing technology to deliver the GlySure System, a safe, accurate, easy-to-use CGM solution for critical care.

With 150 years of combined experience in designing sensors and systems for use in the hospital environment, GlySure has a deep understanding of the need to optimize glycemic control among patients in critical care. We also appreciate that this cannot be achieved by current intermittent testing practices and are committed to addressing this gap, both now and in the future, as we market the GlySure System within the critical care setting and work to expand our product pipeline to address the current and evolving needs of this market.